High Rate of Obstetric Complications in Patients With Essential Thrombocythemia.

essential thrombocythemia jak2 mutation miscarriage obstetric complications placenta diseases

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Dec 2021
Historique:
accepted: 15 12 2021
entrez: 20 1 2022
pubmed: 21 1 2022
medline: 21 1 2022
Statut: epublish

Résumé

Background Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm characterized by persistently elevated platelet count without a clear secondary cause. Although most patients with ET are between 55 and 60 years of age, it has been estimated that 20% of women with ET are diagnosed during reproductive ages. Miscarriage is the most frequent complication of ET that has been hypothesized to be caused by microcirculatory disturbances and placental microinfarction. Furthermore, pregnant patients with ET are at increased risk of other pregnancy complications such as preterm delivery and intrauterine growth restriction. Methods This study was planned to evaluate pregnancy outcomes and predictors of obstetric complications in pregnant women with essential thrombocythemia (ET). The data of 21 patients with ET were analyzed retrospectively between 2016 and 2020. Age, parity, history of miscarriage, presence of Janus kinase 2 (JAK2) mutation, history of thrombotic events, treatment of thrombocytosis during pregnancy, and obstetrical outcomes including miscarriage were compared. Results Patients with ET had a significantly higher rate of history of two or more previous miscarriages. Miscarriage and obstetric complications in pregnant women with ET were found to be significantly higher than in the control group. Patients with ET with obstetric complications or miscarriage more frequently had a platelet count of >1000 × 10

Identifiants

pubmed: 35047285
doi: 10.7759/cureus.20449
pmc: PMC8760033
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e20449

Informations de copyright

Copyright © 2021, İskender et al.

Déclaration de conflit d'intérêts

SYE, DI, MA, and MCI contributed to the collection of data and writing of the manuscript. FA, TÇ, and BTÇ contributed to the analysis of the data and writing of the manuscript. DI and MKÇ followed up patients with hematological consultation. All authors approved the final version of the manuscript.

Références

Obstet Gynecol. 1985 Mar;65(3 Suppl):18S-19S
pubmed: 3974973
Life (Basel). 2021 Jul 10;11(7):
pubmed: 34357048
Am J Hematol. 1987 Jul;25(3):345-7
pubmed: 3605078
Blood. 2007 Jul 15;110(2):485-9
pubmed: 17426257
Am J Obstet Gynecol. 1988 Jul;159(1):127-8
pubmed: 3394731
Am J Hematol. 2009 Oct;84(10):636-40
pubmed: 19705431
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Obstet Gynecol. 2013 Nov;122(5):1122-1131
pubmed: 24150027
Eur J Haematol. 2009 May;82(5):350-3
pubmed: 19243425
Cancer Causes Control. 1999 Feb;10(1):35-42
pubmed: 10334640
Ultrasound Obstet Gynecol. 2017 Oct;50(4):492-495
pubmed: 28741785
Leuk Res. 2021 Mar;102:106500
pubmed: 33556743
Ultrasound Obstet Gynecol. 2016 Sep;48(3):333-9
pubmed: 26909664
Leuk Res. 2020 Nov;98:106459
pubmed: 33022566
J Thromb Haemost. 2008 Apr;6(4):632-7
pubmed: 18248600
Leuk Lymphoma. 2014 Mar;55(3):595-600
pubmed: 23768070
Medicine (Baltimore). 2019 Jun;98(26):e16203
pubmed: 31261566
J Matern Fetal Neonatal Med. 2021 Apr 1;:1-5
pubmed: 33792458
Hemasphere. 2021 Jan 27;5(2):e521
pubmed: 33880431

Auteurs

Dicle İskender (D)

Department of Hematology and Bone Marrow Transplantation, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, TUR.

Seval Yılmaz-Ergani (S)

Obstetrics, Etlik Zubeyde Hanım EAH, Ankara, TUR.

Munevver Aksoy (M)

Obstetrics, Etlik Zubeyde Hanım EAH, Ankara, TUR.

Betul Tokgoz (B)

Obstetrics, Etlik Zubeyde Hanım EAH, Ankara, TUR.

Mujde Can Ibanoglu (MC)

Obstetrics, Etlik Zubeyde Hanım EAH, Ankara, TUR.

Merih Kızıl Çakar (M)

Department of Hematology and Bone Marrow Transplantation, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, TUR.

Turhan Caglar (T)

Obstetrics and Gynecology, Etlik Zubeyde Hanım EAH, Ankara, TUR.

Fevzi Altuntas (F)

Department of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, TUR.

Classifications MeSH